Company Analysis

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE: DNA · Biological Products, (No Diagnostic Substances) · Boston, MA · filing with the SEC since 2020
Grade4.5
◀ Past 4.1● Present 5.1▶ Future 4.2
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedFeb 26, 2026Feb 25, 2025Feb 29, 2024Mar 13, 2023Mar 29, 2022··
Revenue170,155227,043251,455477,706313,83776,65754,184
For lenders
Net interest income····-9,65512,193-48,237
Research and development243,773424,061580,6211,052,6431,149,662159,76796,299
General and administrative183,290246,161385,0251,429,799862,95238,30629,483
Total operating expenses485,433786,8001,115,8612,686,6582,142,304213,684125,782
Operating income-315,278-559,757-864,406-2,208,952-1,828,467-137,027-71,598
Interest expense094931062,3732,3852,421
Interest and investment income22,61638,61257,21720,2628372,5825,756
Share of profit of equity-method investments00-2,635-43,761-77,284-396-27,533
Other income (expense), net1,67812,249-28,53487,553-9,65512,193·
Income before income taxes-313,600-547,508-892,940-2,121,399-1,838,122-124,834-119,835
Income tax expense-837-479-71-15,027-1,4801,88922
Net income including non-controlling interests-312,763-547,029-892,869-2,106,372-1,836,642-126,723-119,857
Net income to non-controlling interests·00-1,443-6,595-114-530
Net income-312,763-547,029-892,869-2,104,929-1,830,047-126,609-119,327
Earnings per share, basic-5.64-10.54-18.37r-50.15r-54.00b-4.00b-4.00b
Earnings per share, diluted-5.64-10.54-18.37r-50.20r-55.60b-4.00b-4.00b
Weighted average shares, basic55,457,67651,894,63948,610,507r41,976,537r33,996,225rb31,869,173b28,725,010b
Weighted average shares, diluted55,457,67651,894,63948,610,507r41,995,972r34,009,325rb31,869,173b28,725,010b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-40 reverse split of Aug 2024.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton DNA · research, not advice